Capitalizing on a Teachable Moment to Promote Smoking Cessation
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02276664 |
Recruitment Status :
Completed
First Posted : October 28, 2014
Last Update Posted : August 13, 2020
|
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborator:
James and Esther King Biomedical Research Program
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date ICMJE | October 21, 2014 | ||||
First Posted Date ICMJE | October 28, 2014 | ||||
Last Update Posted Date | August 13, 2020 | ||||
Actual Study Start Date ICMJE | October 20, 2014 | ||||
Actual Primary Completion Date | June 21, 2019 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures ICMJE |
|
||||
Original Primary Outcome Measures ICMJE |
Number of Focus Group Participants Providing Feedback [ Time Frame: 4 months ] Goal: 20 - 36 participants will respond to a series of questions to identify their perspectives about benefits and barriers to quitting, perceived risk of continued smoking, and cessation motivations relevant to the teachable moment model generally, and spiral CT, specifically.
|
||||
Change History | |||||
Current Secondary Outcome Measures ICMJE |
|
||||
Original Secondary Outcome Measures ICMJE |
Number of Participants Who Stopped Smoking - Post Modified Smoking-Cessation Intervention [ Time Frame: 3 months ] Pilot Test of Smoking-Cessation Intervention Modification. Efficacy data will support a subsequent NCI application for a fully-powered randomized controlled trial.
|
||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title ICMJE | Capitalizing on a Teachable Moment to Promote Smoking Cessation | ||||
Official Title ICMJE | Capitalizing on a Teachable Moment to Promote Smoking Cessation | ||||
Brief Summary | The purpose of this study is to develop and test a self-help smoking cessation treatment for patients receiving a lung cancer screening computed tomography (CT) scan. | ||||
Detailed Description | Conduct Formative Research (Months 1 - 4): Identification of emergent themes and responses to existing booklets. Adapt and Refine Booklets (Months 5 - 8): Advanced drafts of booklets. Final Reactions to Draft Booklets (Months 9 - 12): Series of smoking cessation booklets for spiral computed tomography (CT) patients. |
||||
Study Type ICMJE | Interventional | ||||
Study Phase ICMJE | Not Applicable | ||||
Study Design ICMJE | Allocation: Randomized Intervention Model: Factorial Assignment Masking: None (Open Label) Primary Purpose: Prevention |
||||
Condition ICMJE | Smoking Cessation | ||||
Intervention ICMJE |
|
||||
Study Arms ICMJE |
|
||||
Publications * | Not Provided | ||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status ICMJE | Completed | ||||
Actual Enrollment ICMJE |
35 | ||||
Original Estimated Enrollment ICMJE |
116 | ||||
Actual Study Completion Date ICMJE | June 21, 2019 | ||||
Actual Primary Completion Date | June 21, 2019 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria ICMJE | Inclusion Criteria: Study 1
Study 2
|
||||
Sex/Gender ICMJE |
|
||||
Ages ICMJE | 18 Years and older (Adult, Older Adult) | ||||
Accepts Healthy Volunteers ICMJE | Yes | ||||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
Listed Location Countries ICMJE | United States | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number ICMJE | NCT02276664 | ||||
Other Study ID Numbers ICMJE | MCC-17952 4KB05 ( Other Identifier: James and Esther King Biomedical Research Program ) |
||||
Has Data Monitoring Committee | No | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement ICMJE | Not Provided | ||||
Responsible Party | H. Lee Moffitt Cancer Center and Research Institute | ||||
Study Sponsor ICMJE | H. Lee Moffitt Cancer Center and Research Institute | ||||
Collaborators ICMJE | James and Esther King Biomedical Research Program | ||||
Investigators ICMJE |
|
||||
PRS Account | H. Lee Moffitt Cancer Center and Research Institute | ||||
Verification Date | August 2020 | ||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |